Soft Tissue Augmentation for Immediate Dental Implants
Trial Summary
What is the purpose of this trial?
This trial is testing two types of grafts to help support the bone and gum tissue around a new tooth implant. It focuses on patients with thin gum and bone tissue, who are at higher risk for aesthetic problems. The study will compare the effectiveness of using the patient's own tissue versus a collagen matrix. Collagen matrices have been promoted as an alternative for augmenting soft tissue around dental implants.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are on long-term medications that affect bone metabolism, you may not be eligible to participate.
What data supports the effectiveness of the treatment Soft Tissue Augmentation for Immediate Dental Implants?
Research shows that soft tissue augmentation, including connective tissue grafting (CTG), can significantly enhance the thickness of soft tissue at dental implant sites, which is important for the stability and appearance of the implant. CTG has been found to be more effective than other methods like xenogenic collagen matrix (XCM) in improving soft tissue thickness before prosthetic treatment.12345
Is soft tissue augmentation for dental implants safe for humans?
Soft tissue augmentation for dental implants, including techniques like connective tissue grafting (CTG) and using xenogenic collagen matrix (XCM), has been studied in humans and is generally considered safe. However, most studies have short-term follow-ups, so more research is needed to confirm long-term safety.13456
How does the 'No Soft Tissue Augmentation' treatment for immediate dental implants differ from other treatments?
The 'No Soft Tissue Augmentation' treatment for immediate dental implants is unique because it does not involve additional procedures to increase soft tissue thickness, unlike other methods that use grafts or techniques to enhance tissue around the implant. This approach may be simpler and less invasive, focusing solely on the implant placement without altering the surrounding soft tissue.478910
Research Team
Shaoping Zhang, DDS, MS, PhD
Principal Investigator
University of Iowa
Eligibility Criteria
This trial is for adults aged 18-95 with a single tooth needing replacement in the upper front area, who maintain good oral hygiene and have adequate bone support for an implant. Smokers, pregnant individuals, those with certain medical conditions or treatments affecting bone health or healing are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Immediate implant placement with or without soft tissue augmentation using CTG or VCMX
Early Healing
Monitoring of dynamic changes in bone crest and soft tissue using ultrasonography
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- CTG
- No Soft Tissue Augmentation
- VCMX Graft
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Iowa
Lead Sponsor